Surface modification of biomimetic PLGA-(ASP-PEG) matrix with RGD-containing peptide: a new non-viral vector for gene transfer and tissue engineering

Abstract

RGD-containing peptide (K16-GRGDSPC), characterized as non-viral gene vectors, was fabricated to modify the surface of PLGA-[ASP-PEG] matrix, which offered the foundation for gene transfer with porous matrix of gene activated later. Peptide was synthesized and matrix was executed into chips A, B and chip C. Chip C was regarded as control. Chips A and B were reacted with cross-linker. Then chip A was reacted with peptide. MS and HPLC were used to detect the MW and purity of peptide. Sulphur, existing on the surface of biomaterials, was detected by XPS. The purity of un-reacted peptide in residual solution was detected by a spectrophotometer. HPLC shows that the peptide purity was 94%–95%, and MS shows that the MW was 2 741.3307. XPS reveals that the binding energy of sulphur was 164 eV and the ratio of carbon to sulphur (C/S) was 99.746:0.1014 in reacted chip A. The binding energy of sulphur in reacted chip B was 164 eV and 162 eV, C/S was 99.574:0.4255, and there was no sulphur in chip C. Peptide was manufactured and linked to the surface of biomimetic and 3-D matrix, which offered the possibilities for gene transfer and tissue engineering with this new kind of non-viral gene vector.

Keywords

tissue engineering / gene transfection / biomimetic material / non-viral vector / RGD peptide

References

[1] Nasseri B, Ogawa K, Vacanti J. Tissue Engineering: An Evolving 21st-century Science to Provide Biologic Replacement for Reconstruction and Transplantation [J]. Surgery, 2001, 130(5): 781-784.

[2] Bianco P, Robey P. Stem Cells in Tissue Engineering [J]. Nature, 2001, 414(6859): 118-121.

[3] Collins L, Gustafsson K, Fabre J. Tissue-binding Properties of a Synthetic Peptide DNA Vector Targeted to Cell Membrane Integrins: a Possible Universal Nonviral Vector for Organ and Tissue Transplantation [J]. Transplantation, 2000, 69(6): 1 041-1 050.

[4] Ma H, Diamond S. Nonviral Gene Therapy and Its Delivery Systems [J]. Curr Pharm Biotechnol., 2001, 2(1): 1-17.

[5] Louise C, Kenth G, John W, . Tissue-binding Properties of a Synthetic Peptide DNA Vector Targeted to Cell Membrane Integrins [J]. Transplantation, 2000, 69: 6-6.

[6] Richardson T, Murphy W, Mooney D. Polymeric Delivery of Proteins and Plasmid DNA for Tissue Engineering and Gene Therapy [J]. Crit Rev. Eukaryot Gene Expr., 2001, 11(1–3): 47-58.

[7] Shewring L, Collins L, Lightmao SL, . The Non-viral Vector System for Efficient Gene Transfering to Corneal Cell via Membrane Integrin [J]. Transplantation, 1997, 64: 763-763.